The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, conducted an inspection visit to several facilities in Jeddah, including the Authority's branch office in the Western Region. This visit aimed to monitor operational progress and ensure the effectiveness of services to safeguard product safety. It is part of a series of routine tours across the Kingdom of Saudi Arabia to enhance oversight of products under the SFDA's jurisdiction.

The Saudi Food and Drug Authority (SFDA) advises that ginseng (scientifically known as Panax Ginseng), used in alternative medicine as a general tonic to enhance energy levels and mitigate stress, should be used with caution. High-dose consumption may result in side effects such as insomnia and high blood pressure. Furthermore, pregnant and lactating women are advised to avoid ginseng due to a lack of safety data.

H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), recently conducted an inspection tour of the Authority’s Eastern Province branch, visiting several affiliated facilities.

The Saudi Food and Drug Authority (SFDA) held a workshop at its headquarters in Riyadh entitled “Consultative Sessions for Registering, Advertising, and Promoting Food, Feed, and Cosmetic Products.” The workshop, presented by several specialists from the SFDA, highlighted the mechanisms and procedures for registering, advertising, and promoting food, feed, and cosmetic products.

The Saudi Food and Drug Authority (SFDA) has intensified its field visits to food factories and distribution centers across various cities and regions of Saudi Arabia. This initiative aims to ensure the availability of necessary licenses, verify the existence and effectiveness of the Hazard Analysis Critical Control Point (HACCP) system, and confirm the presence of an effective tracking system.